|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
6689691 |
005 |
20130306150300.0 |
008 |
070731s2008 pauab b 001 0 eng |
003 |
ICU |
015 |
|
|
|a GBA796403
|2 bnb
|
016 |
7 |
|
|a 101462017
|2 DNLM
|
016 |
7 |
|
|a 013807774
|2 Uk
|
019 |
|
|
|a 144226344
|a 718407139
|
020 |
|
|
|a 9781416028826
|
020 |
|
|
|a 141602882X
|
035 |
|
|
|a (OCoLC)182662369
|z (OCoLC)144226344
|z (OCoLC)718407139
|
035 |
|
|
|a om1230756
|
040 |
|
|
|a NLM
|b eng
|c NLM
|d UKM
|d VAM
|d WAU
|d BTCTA
|d BAKER
|d BWX
|d YDXCP
|d CDX
|d CHRRO
|d BDX
|
042 |
|
|
|a ukblcatcopy
|a nlmcopyc
|
043 |
|
|
|a d------
|
049 |
|
|
|a CGUA
|
050 |
|
4 |
|a RC606.6
|b .G6 2008
|
060 |
0 |
0 |
|a 2007 M-566
|
060 |
1 |
0 |
|a WC 503
|b G56235 2008
|
072 |
|
7 |
|a s1me
|2 rero
|
082 |
0 |
4 |
|a 616.979206
|2 22
|
245 |
0 |
0 |
|a Global HIV/AIDS medicine /
|c edited by Paul A. Volberding ... [et al.] ; associate editor, Joel E. Gallant ; assistant editor, Carrie Clark.
|
260 |
|
|
|a Philadelphia, PA :
|b Saunders/Elsevier,
|c 2008.
|
300 |
|
|
|a xx, 830 p. :
|b ill., maps ;
|c 28 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a The global epidemiology of HIV/AIDS -- The origins and diversification of HIV -- Molecular biology of HIV: implications for new therapies -- The immune response to HIV -- Viral and host determinants of HIV-1 disease progression -- Acute HIV infection -- Biology of HIV-1 transmission -- The design of a global AIDS vaccine -- HIV prevention -- Laboratory testing for HIV infection -- Testing and counseling -- New HIV drug development -- Overview of antiretroviral therapy -- Development and transmission of HIV drug resistance -- Clinical implications of HIV fitness and virulence -- Pharmacology of antiretroviral drugs -- Complications resulting from antiretroviral therapy for HIV infection -- HIV immune reconstitution inflammatory syndrome -- Adherence to HIV antiretrovial therapy in resource-limited settings -- Oral complications of HIV infection --Ocular manifestations -- Global HIV dermatology -- Gastrointestinal disorders in HIV -- Primary neurological manifestation of HIV/AIDS -- Psychiatric barriers and the international AIDS epidemic -- Cardiovascular complications of HIV infection -- Endocrine complications of HIV infection -- Renal complications of HIV infection -- Pneumocystis pneumonia -- Other HIV-related pneumonias -- HIV-associated tuberculosis -- Disseminated Mycobacterium avium complex and other atypical mycobacterial infections -- Candida in HIV infection -- Cryptococcosis and other fungal infections (Histoplasmosis and Coccidioidomycosis) in HIV-infected patients -- Infection due to Penicillium marneffei -- AIDS-associated toxoplasmosis -- Hepatitis virus infections -- Bartonella infections in HIV-infected individuals -- Management of Herpesvirus infections (Cytomegalovirus, Herpes Simplex virus, and Varicella-Zoster virus) -- HIV-associated neoplasia -- Managing HIV infection in children and adolescents --
|
505 |
0 |
|
|a Special issues regarding women with HIV infection -- Prevention of mother-to-child transmission of HIV-1 -- HIV disease among substance users: treatment issues -- Models of care: HIV care in the urban USA -- Antiretrovial therapy of drug-resistant HIV -- Complementary and alternative medicine -- The HIV-infected international traveler -- HIV transmission and its prevention in Africa -- HIV transmission and its prevention in Asia -- HIV transmission and its prevention in Eastern Europe -- Vaginal microbicides against HIV -- Implications and management of malnutrition -- Antiretroviral therapy in resource-poor settings: challenges, research priorities, oppportunities -- Antiretroviral treatment and follow-up of HIV-infected children in resource-limited settings -- Epidemiology, natural history and treatment of HIV-2 infections -- Affordable CD4 T-cell enumeration and HIV/AIDS viral load monitoring in resource-poor settings -- Essential medicines for HIV/AIDS -- Pharmacoeceonomics of HIV/AIDS treatment -- Logistics and models of implementing HAART in resource-constrained settings -- Universal access to antiretroviral therapy: the Brazilian experience -- Surveillance of antiretroviral drug resistance in resource-poor settings -- Post-exposure prevention -- Selected NGOs active in HIV and web links -- Etiology and management of diarrhea in HIV-infected patients and impact on antiretroviral therapy -- Malaria and HIV infection -- The role of unsterile injections in the HIV pandemic -- The economic impact of HIV/AIDS in developing countries: systematic under-estimation - The long wave of HIV/AIDS: a special case of pathogen-host-environment interactions -- The growing problem of AIDS orphans -- International funding mechanisms for AIDS care and prevention.
|
650 |
1 |
2 |
|a HIV Infections.
|
650 |
2 |
2 |
|a Acquired Immunodeficiency Syndrome.
|
650 |
|
0 |
|a HIV infections.
|0 http://id.loc.gov/authorities/subjects/sh91004036
|
650 |
|
0 |
|a HIV infections
|x Treatment.
|0 http://id.loc.gov/authorities/subjects/sh2020005572
|
650 |
|
0 |
|a HIV infections
|x Treatment
|z Developing countries.
|
650 |
|
0 |
|a HIV infections
|x Government policy.
|
650 |
|
0 |
|a HIV infections
|x Epidemiology.
|
650 |
|
7 |
|a HIV infections.
|2 fast
|0 http://id.worldcat.org/fast/fst00949871
|
650 |
|
7 |
|a HIV infections
|x Epidemiology.
|2 fast
|0 http://id.worldcat.org/fast/fst00949883
|
650 |
|
7 |
|a HIV infections
|x Government policy.
|2 fast
|0 http://id.worldcat.org/fast/fst00949884
|
650 |
|
7 |
|a HIV infections
|x Treatment.
|2 fast
|0 http://id.worldcat.org/fast/fst00949907
|
651 |
|
7 |
|a Developing countries.
|2 fast
|0 http://id.worldcat.org/fast/fst01242969
|
700 |
1 |
|
|a Volberding, Paul.
|0 http://id.loc.gov/authorities/names/n85304131
|1 http://viaf.org/viaf/92365081
|
776 |
0 |
8 |
|i Online version:
|t Global HIV/AIDS medicine.
|d Philadelphia, PA : Saunders/Elsevier, 2008
|w (OCoLC)608586681
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 354f3dc5-494c-5a24-96dc-b470e0a7d6ef
|s f62da3df-e8a8-5b56-baed-1cc154f6890d
|
928 |
|
|
|t Library of Congress classification
|a RC606.6 .G6 2008
|l JCL
|c JCL-Sci
|i 5278209
|
927 |
|
|
|t Library of Congress classification
|a RC606.6 .G6 2008
|l JCL
|c JCL-Sci
|e VAND
|e CRERAR
|b 77157718
|i 8339046
|